Tagged With Pharmaceuticals

The world's biggest fund managers are dumping tech to an extent not seen since the financial crisis — here's what they're scooping up instead


Evidence is mounting that psychedelic drugs can help treat diseases. Here are the most promising uses


A drug derived from marijuana has triggered the first federal shift on cannabis in half a century, and experts predict an avalanche effect



A startup with ties to Bayer has inked a $122 million deal to make lab-grown marijuana — and it's eyeing the pharma industry


Stanford researchers are figuring out how ketamine fights depression — and why the drug has been called 'the most important discovery in half a century'


The drug maker behind the first FDA-approved medication derived from marijuana has revealed how much it will cost



DNA-testing company 23andMe has signed a $300 million deal with a drug giant. Here's how to delete your data if that freaks you out.


Doctors are calling out a new drug that helps people with addiction for costing more than $1,700 a week — while a generic costs just $1


A drug derived from marijuana has become the first to win federal approval, and experts predict an avalanche effect


A pharma CEO says a new depression drug could have lasting effects after one short course, like antibiotics — here's what experts think


A 'breakthrough' depression drug inspired by ketamine is attracting more attention from big pharma


A drug derived from marijuana just got a big lift that will likely make it the first of its kind to get federal approval



The first drug for opioid withdrawal has gotten the green light -- and it targets risky symptoms that others ignore


Psychedelic drugs appear to fundamentally reorganise the brain -- and they're starting to turn into approved treatments


A depression drug that researchers have called 'the most important discovery in half a century' just got a big lift


A bidding war for the maker of Adderall stalled out after just 4 hours



A powerful drug derived from marijuana just got a major green light on its way to FDA approval


Ketamine could become the first new depression drug in more than 30 years


DIGITAL HEALTH BRIEFING: New Amazon hire could indicate a move into EHR -- Home-DNA test takes aim at heart conditions -- How VR can give specialists a confidence boost


'Pharma bro' Martin Shkreli has been sentenced to 7 years in prison